In Silico Evaluation of the Antibacterial Potential of Methanolic Lo’i-Keta Extract Against DNA Gyrase in Staphylococcus aureus and Pseudomonas aeruginosa
DOI:
https://doi.org/10.33394/bioscientist.v14i3.19511Keywords:
Lo’i-keta, antibacterial activity, in silico, Staphylococcus aureus, Pseudomonas aeruginosaAbstract
This study aimed to evaluate the antibacterial potential of bioactive compounds identified in the methanolic extract of lo’i-keta against DNA gyrase from Staphylococcus aureus (PDB ID: 3G75) and Pseudomonas aeruginosa (PDB ID: 6M1S) using an in silico approach. Bioactive compounds were identified by gas chromatography–mass spectrometry (GC–MS). Ligand preparation and molecular docking were subsequently performed using PyRx 0.8, while ligand–protein interactions were visualized using Discovery Studio. Ciprofloxacin was used as the positive control. GC–MS analysis detected 20 compound peaks, of which 13 compounds were validated and included in the docking analysis. Molecular docking results showed that cyclooctacosane exhibited the strongest binding affinity toward the DNA gyrase of S. aureus and P. aeruginosa, with binding energies of −8.3 and −8.2 kcal/mol, respectively. These values were more favorable than those of ciprofloxacin, which showed binding affinities of −7.7 and −7.4 kcal/mol, respectively. In addition, dioctyl benzene-1,2-dicarboxylate displayed a residue interaction pattern similar to that of ciprofloxacin within the active site of DNA gyrase. Hexadecanoic acid (palmitic acid) exhibited a more moderate binding affinity but was present at a relatively high abundance in the extract. These findings indicate that several bioactive compounds in lo’i-keta may form stable interactions with DNA gyrase, supporting its potential as a molecular target for antibacterial activity. Based on the in silico results, cyclooctacosane was identified as the leading candidate DNA gyrase inhibitor, while dioctyl benzene-1,2-dicarboxylate and hexadecanoic acid may serve as supporting candidates for the development of lo’i-keta-based antibacterial agents. This study provides a scientific basis for the traditional use of lo’i-keta; however, further in vitro and in vivo investigations are required to validate these findings.
References
Abbas, M. A., Lee, G.-Y., Sayem, S. A. J., Lee, S.-J., & Park, S.-C. (2025). Integrated phytochemical profiling, GC–MS characterization, and in silico evaluation of antimicrobial activities of plant extracts. Antioxidants, 14(9), 1114. https://doi.org/10.3390/antiox14091114
Alfadli, R., & Khairunisa, S. (2024). Prevalensi penyakit kulit infeksi dan non-infeksi di Poliklinik Kulit dan Kelamin RSUD Jagakarsa periode Februari 2023–Januari 2024. Jurnal Kedokteran Meditek, 30, 151–156.
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014). Mechanism of quinolone action and resistance. Biochemistry, 53(10), 1565–1574. https://doi.org/10.1021/bi5000564
Arizka, D. I., & Hervina. (2021). Hubungan personal hygiene terhadap kejadian pioderma pada pemulung di Tempat Pembuangan Akhir (TPA) Terjun Kecamatan Medan Marelan. [Nama jurnal belum tersedia], 5.
Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/nar/gky318
Casillas-Vargas, G., Ocasio-Malavé, C., Medina, S., Morales-Guzmán, C., Del Valle, R. G., Carballeira, N. M., & Sanabria-Ríos, D. J. (2021). Antibacterial fatty acids: An update of possible mechanisms of action. Molecules, 26(13), 3847. https://doi.org/10.3390/molecules26133847
Collin, F., Karkare, S., & Maxwell, A. (2011). Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives. Applied Microbiology and Biotechnology, 92, 479–497. https://doi.org/10.1007/s00253-011-3557-z
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, Article 42717. https://doi.org/10.1038/srep42717
Desbois, A. P., & Smith, V. J. (2021). Antibacterial free fatty acids: Activities, mechanisms, and biomedical potential. Applied Microbiology and Biotechnology, 105, 3831–3847. https://doi.org/10.1007/s00253-021-11279-7
Filimonov, D. A., Druzhilovskiy, D. S., Lagunin, A. A., Gloriozova, T. A., Rudik, A. V., Dmitriev, A. V., Pogodin, P. V., & Poroikov, V. V. (2023). Prediction of biological activity spectra of organic compounds using PASS. Pharmaceutical Chemistry Journal, 56(10), 1081–1089. https://doi.org/10.1007/s11094-023-02841-2
Hossain, T. J. (2024). Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations. European Journal of Microbiology & Immunology, 14(2), 97–115. https://doi.org/10.1556/1886.2024.00035
Jorgenson, M. A., & Young, K. D. (2016). Interrupting biosynthesis of O antigen or the lipopolysaccharide core produces morphological defects in Escherichia coli by sequestering undecaprenyl phosphate. Journal of Bacteriology, 198(22), 3070–3079. https://doi.org/10.1128/JB.00550-16
Junaidin, Yuliana, S., & Rahman, A. (2022). Analisis persepsi masyarakat dengan sikap memilih pengobatan tradisional Lo’i Keta daripada ke rumah sakit di era pandemi COVID-19. Jurnal Ilmiah STIKES Citra Delima Bangka Belitung, 5, 72–77. https://doi.org/10.33862/citradelim
Kim, Y. G., Lee, J. H., Raorane, C. J., Oh, S. T., Park, J. G., & Lee, J. (2022). Inhibition of Staphylococcus aureus biofilm formation and virulence factor production by petroselinic acid and other unsaturated C18 fatty acids. Microbiology Spectrum, 10(4), e01330-22. https://doi.org/10.1128/spectrum.01330-22
Lagunin, A. A., Rudik, A. V., Druzhilovskiy, D. S., Gloriozova, T. A., Filimonov, D. A., Sastry, N. G., & Poroikov, V. V. (2021). Machine learning approaches for prediction of biological activity profiles. Journal of Chemical Information and Modeling, 61(11), 5139–5153. https://doi.org/10.1021/acs.jcim.1c00627
Ma, Z., Ajibade, A., & Zou, X. (2024). Docking strategies for predicting protein–ligand interactions and their application to structure-based drug design. Communications in Information and Systems, 24(3), 199–230.
Müller, A., Wenzel, M., Strahl, H., Grein, F., Saaki, T. N. V., Kohl, B., Siersma, T., Bandow, J. E., Sahl, H.-G., Schneider, T., & Hamoen, L. W. (2022). Targeting undecaprenyl phosphate recycling as an antibacterial strategy. Trends in Microbiology, 30(9), 861–873. https://doi.org/10.1016/j.tim.2022.03.005
Qin, J., Hong, Y., Maczuga, N. T., Morona, R., & Totsika, M. (2025). Tolerance mechanisms in polysaccharide biosynthesis: Implications for undecaprenol phosphate recycling in Escherichia coli and Shigella flexneri. PLOS Genetics, 21(1), e1011591. https://doi.org/10.1371/journal.pgen.1011591
Safari, D. A., Musyarrafah, Rozikin, & Rini, S. (2025). [Judul artikel belum tersedia]. Jurnal Ilmiah Biologi, 13.
Salman, M., Sharma, P., Kumar, M., Ethayathulla, A. S., & Kaur, P. (2022). Targeting novel sites in DNA gyrase for development of antimicrobials. Briefings in Functional Genomics, 22(2), 180–194. https://doi.org/10.1093/bfgp/elac029
Shah, K., Mujwar, S., Gupta, J. K., Shrivastava, S. K., & Mishra, P. (2019). Molecular docking and in silico cogitation validate mefenamic acid prodrugs as human cyclooxygenase-2 inhibitors. Assay and Drug Development Technologies, 17, 285–291.
Singh, P., et al. (2023). In silico identification of multitarget antibacterial agents against resistant bacteria. Frontiers in Microbiology, 14, 1182456.
Sit, B., Crowley, V. M., Bhattacharya, A., et al. (2023). Undecaprenyl phosphate translocases confer conditional microbial fitness. Nature, 613, 721–728.
Stenz, L., François, P., Fischer, A., Huyghe, A., Tangomo, M., Hernandez, D., Cassat, J., Linder, P., & Schrenzel, J. (2020). Unsaturated fatty acids control biofilm formation of Staphylococcus aureus and other Gram-positive bacteria. Antibiotics, 9(11), 788. https://doi.org/10.3390/antibiotics9110788
Teoh, W. Y., et al. (2023). GC–MS analysis of bioactive metabolites in medicinal plant extracts and their biological relevance. Separations, 10(3), 215.
Wilson, M. G., & Pandey, S. (2020). Pseudomonas aeruginosa. StatPearls Publishing.
World Health Organization. (2024). WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization.
Yakupu, A., Aimaier, R., Yuan, B., Chen, B., Cheng, J., Zhao, Y., Peng, Y., Dong, J., & Lu, S. (2023). The burden of skin and subcutaneous diseases: Findings from the Global Burden of Disease Study 2019. Frontiers in Public Health, 11, 1145513. https://doi.org/10.3389/fpubh.2023.1145513
Yasir, M., Willcox, M. D. P., & Dutta, D. (2020). Action of antimicrobial fatty acids on Gram-positive and Gram-negative bacteria. Current Topics in Medicinal Chemistry, 20(30), 2569–2582.
Yoon, B. K., Jackman, J. A., Valle-González, E. R., & Cho, N. J. (2018). Antibacterial free fatty acids and monoglycerides: Biological activities, experimental testing, and therapeutic applications. International Journal of Molecular Sciences, 19(4), 1114. https://doi.org/10.3390/ijms19041114
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 M. Agung Wisnu Pratama, Rozikin, Made Ayu Mirah Wulandari, Resna Hermawati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
